FIELD: medicine, pharmaceutics.
SUBSTANCE: invention refers to pharmaceutical chemistry, more specifically to a method for producing octreotide by a liquid phase method by oxidative ring formation with using potassium triiodide in a water-methanol solution as an oxidative and unblocking reagent.
EFFECT: method is characterised by simplicity, absence of toxic reagents and high yield of an end product.
2 ex
| Title | Year | Author | Number |
|---|---|---|---|
| PROTECTED DERIVATIVES OF OCTREOTIDE | 2001 |
|
RU2196144C1 |
| METHOD OF PRODUCING CYCLIC PEPTIDE | 2010 |
|
RU2494105C2 |
| SHORT PEPTIDES WITH ANTITUMOUR ACTIVITY | 2016 |
|
RU2648357C2 |
| SOLID-PHASE SYNTHESIS OF PEPTIDES WITH BOC AND FMOC PROTECTIVE GROUPS | 2007 |
|
RU2439075C2 |
| ADAMANTIL DERIVATIVES OF SHORT PEPTIDES WITH ANTITUMOUR ACTIVITY | 2016 |
|
RU2646795C1 |
| CYCLIC OCTAPEPTIDE, RADIOPHARMACEUTICAL AGENT BASED THEREON AND METHOD OF USING RADIOPHARMACEUTICAL AGENT TO PRODUCE MEDICINAL (PHARMACEUTICAL) AGENTS FOR TREATING NEOPLASMS EXPRESSING SOMATOSTATIN RECEPTORS | 2013 |
|
RU2528414C1 |
| CHIMERIC ANALOGS OF SOMATOSTATIN-DOPAMINE | 2002 |
|
RU2277539C2 |
| OCTAPEPTIDE FOR PRODUCING RADIOTRACERS, RADIOTRACER BASED THEREON METHOD OF DIAGNOSING TUMOURS, EXPRESSING SOMATOSTATIN RECEPTORS | 2011 |
|
RU2457215C1 |
| MARKED PEPTIDES BINDING HEPATOCYTE GROWTH FACTOR (HGF) FOR VISUALISATION | 2008 |
|
RU2473361C9 |
| SELECTIVE CYCLOPEPTIDES | 2001 |
|
RU2239642C1 |
